<div>Researchers in the United States have defined an antigenic &ldquo;supersite&rdquo; within the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could have important implications for the design of vaccines to protect against coronavirus disease 2019 (COVID-19).</div>